FILTER
LATEST INTERVIEWS
Bráulio de Brito
FOUNDER AND EXECUTIVE CHAIRMAN, TRADINTER AND CHAIRMAN, AECIPA
"Doing business in Angola requires a great deal of imported goods and equipment, which challenges both the companies and the central bank to make foreign currency available. "
Sopiribo Ideriah
GROUP MANAGING DIRECTOR WEST AFRICA, SLB
"Opportunities such as domestic gas and power supply, LNG, CNG, fertilizer plants, etc., present a huge untapped market that could sustain our presence in these regions for many years."
Pat Risner
PRESIDENT OF HERMOSA, SOUTH32
"As the only advanced mine project in the US that could produce two federally designated critical minerals — manganese and zinc — Hermosa can help put Arizona in the driver’s seat of the clean energy race."
Jorge Ganoza
CEO, FORTUNA MINING
"Our West African mines deliver the highest margins, with Séguéla being our lowest-cost operation."
Pierre Léveillé
PRESIDENT & CEO, KORYX COPPER
"By early 2025, we would expect to increase the average grade to over 0.40%."
Raul Costa
MANAGING DIRECTOR, TUBOSTRANS
"In addition to the currency challenge, access to capital in order to grow your business is also a challenge in Angola."
Emeka Ene
CEO, THE OIDA GROUP
"Modular approaches to gas monetization are becoming more prevalent due to the inefficiency of large-scale projects in regions with limited industrial infrastructure."
Zaidi Mohd
GENERAL MANAGER, ODFJELL TANKERS
"The Asian offices, from Singapore to Shanghai to Seoul, provide the latest market insights to our global customers."
Marcelo Tarkieltaub
REGIONAL DIRECTOR, SOUTHEAST ASIA, ROCKWELL AUTOMATION
"We see a leap from digital manufacturing to fully autonomous manufacturing."
Paulo Misk
COO, LITHIUM IONIC
"The unique geological conditions in the Jequitinhonha Valley favor spodumene crystallization, making it one of the best areas globally for lithium extraction."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
